MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

APLS_BIG copy-svg

Apellis Pharmaceuticals, Inc. (APLS)

APLS_BIG copy-svg

Apellis Pharmaceuticals, Inc. (APLS)

|||

Balance Sheets Overview

Current Ratio
362.68%
Quick Ratio
316.32%
Cash Ratio
142.96%
Debt to Asset Ratio
61.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Accounts receivable, net
    • Cash and cash equivalents
    • Inventory
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term credit facility
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
405,207
466,233
479,171
370,036
Accounts receivable, net
440,299
366,221
345,538
214,131
Inventory
131,408
142,556
122,819
121,000
Prepaid assets
-
-
31,560
29,171
Prepaid and other current assets
49,587
38,303
-
-
Restricted cash
1,520
1,527
1,430
1,430
Other current assets
-
-
10,158
19,842
Total current assets
1,028,021
1,014,840
990,676
755,610
Right-of-use assets
18,945
18,195
19,720
14,637
Property and equipment, net
1,418
1,708
1,927
2,117
Long-term inventory
28,489
34,959
40,909
48,128
Other assets
5,659
5,555
5,491
898
Total assets
1,082,532
1,075,257
1,058,723
821,390
Accounts payable
49,049
56,798
38,602
54,241
Accrued expenses
133,693
166,049
140,322
138,999
Convertible senior notes
93,744
93,662
93,581
-
Current portion of lease liabilities
6,962
7,087
7,022
7,419
Total current liabilities
283,448
323,596
279,527
200,659
Long-term credit facility
362,243
361,664
361,091
360,535
Convertible senior notes
-
0
0
93,500
Lease liabilities
12,807
11,947
13,680
8,313
Other liabilities
9,111
7,903
3,257
2,078
Total liabilities
667,609
705,110
657,555
665,085
Common stock, 0.0001 par value 200,000 shares authorized at march 31, 2026 and december 31, 2025 127,923 shares issued and outstanding at march 31, 2026, and 126,621 shares issued and outstanding at december 31, 2025
13
12
12
12
Additional paid-in capital
3,411,643
3,385,216
3,357,583
3,328,604
Accumulated other comprehensive loss
-2,411
-2,103
-2,400
-2,569
Accumulated deficit
-2,994,322
-3,012,978
-2,954,027
-3,169,742
Total stockholders' equity
414,923
370,147
401,168
156,305
Total liabilities and stockholders' equity
1,082,532
1,075,257
1,058,723
821,390
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$440,299K (87.17%↑ Y/Y)Cash and cashequivalents$405,207K (13.06%↑ Y/Y)Inventory$131,408K (59.34%↑ Y/Y)Prepaid and othercurrent assets$49,587K Restricted cash$1,520K (6.00%↑ Y/Y)Total current assets$1,028,021K (41.27%↑ Y/Y)Long-term inventory$28,489K (-53.03%↓ Y/Y)Right-of-use assets$18,945K (24.22%↑ Y/Y)Other assets$5,659K (392.09%↑ Y/Y)Property and equipment,net$1,418K (-43.60%↓ Y/Y)Total assets$1,082,532K (34.10%↑ Y/Y)Total liabilities andstockholders' equity$1,082,532K (34.10%↑ Y/Y)Total liabilities$667,609K (3.82%↑ Y/Y)Total stockholders'equity$414,923K (152.67%↑ Y/Y)Accumulated deficit-$2,994,322K (4.26%↑ Y/Y)Accumulated othercomprehensive loss-$2,411K (21.05%↑ Y/Y)Long-term credit facility$362,243K (0.62%↑ Y/Y)Total currentliabilities$283,448K (58.90%↑ Y/Y)Lease liabilities$12,807K (39.42%↑ Y/Y)Other liabilities$9,111K (337.19%↑ Y/Y)Additional paid-in capital$3,411,643K (3.54%↑ Y/Y)Common stock, 0.0001par value 200,000...$13K (8.33%↑ Y/Y)Accrued expenses$133,693K (15.11%↑ Y/Y)Convertible senior notes$93,744K (0.35%↑ Y/Y)Accounts payable$49,049K (-11.28%↓ Y/Y)Current portion of leaseliabilities$6,962K (0.26%↑ Y/Y)